Alzheimer's therapeutics market to reach $6.8 billion by 2032

A large patient population is expected to expand the Alzheimer’s therapeutics market at a CAGR of 9.3 percent, suggested a report.

Related Keywords

China ,United States ,India ,America ,Anavex Lifesciences ,Asia Pacific ,Eli Lilly ,Daiichi Sankyo Co ,Alzheimer Therapeutics International ,Amarantus Bioscience Holdings ,Axovant Sciences ,Janssen Pharmaceuticals ,Abbvie Inc ,Ge Healthcare ,Future Market Insights ,Therapeutics International ,North America ,Latin America ,Middle East ,World Alzheimer Report ,Central Europe ,North Africa ,Vie Inc ,Avid Radiopharmaceuticals ,Axon Neuroscience ,